Lineage News

Lineage Cell Therapeutics Analyst Ratings

Benzinga01:18 · Ratings

Trump Media Saw the Largest Increase in Short Interest in October

Seeking AlphaNov 20 23:57

Lineage Cell Therapeutics Entered Into Definitive Agreements With Certain Institutional Investors And With Broadwood Partners, L.P. For The Purchase And Sale Of Up To An Aggregate Of 39,473,688 Of Lineage's Common Shares And Accompanying Warrants To...

BenzingaNov 20 21:08

Express News | Lineage Cell Therapeutics Announces Pricing of up to $66 Million Registered Direct Offering

BreakingsNov 20 21:00

Wells Fargo Maintains Lineage(LINE.US) With Hold Rating

Futu NewsNov 19 16:36 · Ratings

Analysts Offer Insights on Healthcare Companies: Lineage Therap (LCTX), Veeva Systems (VEEV) and Takeda Pharmaceutical Company (TAK)

TipRanksNov 19 14:50 · Ratings

REITs See Q3 FFO Decline Y/Y Despite Higher Net Operating Income, Occupancy

Seeking AlphaNov 19 04:32

D. Boral Capital Initiates Coverage On Lineage Cell Therapeutics With Buy Rating, Announces Price Target of $3

BenzingaNov 18 23:12 · Ratings

Wells Fargo Remains a Hold on Lineage, Inc. (LINE)

TipRanksNov 18 22:06

Lineage Cell Therapeutics, Inc. (LCTX) Q3 2024 Earnings Call Transcript Summary

Futu NewsNov 15 10:51 · Conference Call

Lineage Cell (LCTX) Reports Q3 Loss, Tops Revenue Estimates

Zacks Nov 15 05:30

Lineage Cell Therapeutics 3Q Loss/Shr 2c >LCTX

Dow JonesNov 15 05:06

Lineage Cell Therapeutics Q3 2024 GAAP EPS $(0.02) Beats $(0.04) Estimate, Sales $3.779M Beat $1.033M Estimate

BenzingaNov 15 05:02

Earnings Flash (LCTX) LINEAGE CELL THERAPEUTICS Reports Q3 Revenue $3.8M

MT NewswiresNov 15 05:01

Press Release: Lineage Cell Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Dow JonesNov 15 05:01

Goldman Sachs Maintains Lineage(LINE.US) With Buy Rating, Cuts Target Price to $89

Futu NewsNov 14 07:31 · Ratings

Lineage Cell Therapeutics's Earnings Outlook

BenzingaNov 14 01:03

Lineage Is Maintained at Outperform by RBC Capital

Dow JonesNov 13 23:16 · Ratings

RBC Capital Maintains Lineage(LINE.US) With Buy Rating, Cuts Target Price to $81

Futu NewsNov 13 20:31 · Ratings

Express News | Lineage Inc : UBS Cuts Target Price to $75 From $88

BreakingsNov 12 23:25